Cellectar Biosciences GAAP EPS of -$0.57 misses by $0.05
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Finance & Markets
The Morning Risk Report: Paramount Has Discussed Creating a Board to Ensure CNN’s Independence
Plus: Eli Lilly alleges black market weight loss drug sellers; shippers don’t buy Trump’s Hormuz strait claims
SBS Transit H1 profit down 0.3% on increased energy costs; special dividend of 15.97 cents declared
Revenue grows 5.3%, thanks to increased average fares and ridership on the company’s public transport services
CFTC orders Kalshi to keep operating in response to New York lawsuit
The US Commodity Futures Trading Commission (CTFC) ordered predictions market platform Kalshi to continue operating on Tuesday, opposing multiple state lawsuits against the company.